Researchers estimate the number of people globally living with chronic obstructive pulmonary disease (COPD) will hit 600 ...

Discover why doctors warn against vaping for people with these five health conditions including asthma, heart disease, and ...

University at Buffalo School of Nursing researchers have identified a new benefit of mindfulness for people managing chronic ...

A new study published in the CHEST journal found that ensifentrine, an innovative inhaled therapy, significantly reduces the ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

Individuals with asthma and chronic obstructive pulmonary disease (COPD) were more vulnerable than healthy controls to ...

A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...

Genetic risk scoring improves COPD detection beyond traditional methods, enabling earlier diagnosis and better patient ...

People in rural areas are at greater risk of developing chronic obstructive pulmonary disease (COPD) due to a variety of factors. We explain why.

OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024More prescriptions filled through February ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...